Clinical trial
Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein…
NCT00363987 · Fresenius Kabi, Industry · Completed
Key facts
| NCT number | NCT00363987 |
|---|---|
| Title | Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) |
| Official title | A Multicenter, Randomized, Open-label, Parallel-group, Diabetic Diet-controlled Study to Evaluate the Efficacy and Safety of Compound α-Keto Acid Tablet in Combination With LPD in Delaying the Progress of Type 2 Diabetic Nephropathy |
| Lead sponsor | Fresenius Kabi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathy |
| Intervention type | Drug, Other |
| Interventions | Ketosteril®, diabetic diet |
| Enrollment | 179 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Aug 15, 2006 |
| Last update posted | Sep 2, 2010 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: